FDA Okays First Liquid Form of Antiepileptic Zonisamide

The US Food and Drug Administration has approved zonisamide oral suspension (Zonisade) as adjunctive therapy for partial seizures in adults and teens 16 years and older with epilepsy.
Medscape Medical News